(Q34737815)

4 August 2017

1 reference

title

Persistence of human parvovirus B19 in human tissues (English)

1 reference

4 August 2017

Maria Söderlund-Venermo

1

object named as

Maria Söderlund-Venermo

0 references

Klaus Hedman

5

object named as

Klaus Hedman

1 reference

4 August 2017

Kati Hokynar

2

1 reference

PubMed ID

12116849

4 August 2017

Janne Nieminen

3

1 reference

PubMed ID

12116849

4 August 2017

Henna Rautakorpi

4

1 reference

4 August 2017

1 June 2002

1 reference

4 August 2017

Pathology and Biology

1 reference

4 August 2017

50

1 reference

4 August 2017

5

1 reference

4 August 2017

307-316

1 reference

Parvovirus infections and hypoplastic crisis in sickle-cell anaemia

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Clinical manifestations of human parvovirus B19 in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus infection in early rheumatoid and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Chronic bone marrow failure due to persistent B19 parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Novel human erythrovirus associated with transient aplastic anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Erythrocyte P antigen: cellular receptor for B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus infection revealing hereditary spherocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Six cases of hereditary spherocytosis revealed by human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Parvovirus B19 and chronic arthritis--causal or casual association?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus B19 infection and juvenile chronic polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus arthropathy and rheumatoid factor

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

HLA and acute arthritis following human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistent arthritis after human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus B19 DNA in synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistence of parvovirus B19 in synovial fluid and bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

A study of the role of parvovirus B19 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Rheumatoid arthritis after human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus B19 and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Autoantibodies following parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Autoantibodies and common viral illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

A viral phospholipase A2 is required for parvovirus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistent parvovirus B19 infections in immunocompromised children

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Parvovirus B19 as a cause of acquired chronic pure red cell aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Chronic parvovirus infection in a presumably immunologically healthy woman

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistent infection of human parvovirus B19 in a normal subject

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Evidence for persistence of human parvovirus B19 DNA in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Evidence for persistence of parvovirus B19 DNA in livers of adults

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Human parvovirus B19 as a causative agent for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Microbial DNA in the synovium--a role in aetiology or a mere bystander?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Rubella virus and chronic joint disease: is there an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Chlamydia pneumoniae in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Parvovirus B19 is associated with benign testes as well as testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Antineoplasic activity of parvoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

IgG subclass response to human parvovirus B19 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Impaired gamma interferon responses against parvovirus B19 by recently infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Sequence variability among different parvovirus B19 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Persistent parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Ebola virus defective interfering particles and persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

Site-specific integration by adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900307-3

7 January 2021

10.1016/S0369-8114(02)00307-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12116849